FORM 10-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

May 4, 2020

Period of Report

February 29, 2020

Accession Number

0001104659-20-055760

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →